Overall, TP53 is the most frequently mutated gene in human neoplasias (42–43% mutations [1,3]) with well-established tumor-suppressive activities, while the hot-spot missense mutant variants have been shown to possess oncogenic gain-of-function properties (Figure 1). Here, TP53 is linked to neoplasm.